Funding for HIV-related harm reduction programmes globally is in crisis. There can be no AIDS free generation without targeted efforts with and for people who inject drugs, yet, as this report shows, funding for harm reduction falls dangerously short of estimated need. As a result, coverage of essential HIV and harm reduction programmes targeting people who inject drugs is very low and wholly inadequate to respond effectively to HIV among this community. While this has been the case for some time, the data and policy analysis conducted for this report shows that rather than action being taken to address this problem, the situation looks set to deteriorate.
La Comisión Europea está preparando una tercera fase de este programa, por lo que COPOLAD volverá a principios de 2021.